Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management
Diabetes Technology & Therapeutics ( IF 5.7 ) Pub Date : 2021-10-26 , DOI: 10.1089/dia.2021.0201
Brynn E Marks _{1,

2} , Marissa J Kilberg _{3,

4} , Enid Aliaj ₅ , Kelsey Fredkin ₅ , Jessica Hudson ₅ , Dara Riva ₅ , Christina Román ₅ , Andrea Kelly _{3,

4} , Melissa S Putman _{6,

7,

8}

Affiliation

Background: Diabetes technologies are associated with improvements in glycemic control and health-related quality of life among people with type 1 diabetes (T1D). Use and perceptions of continuous glucose monitors (CGM) and insulin pumps within the cystic fibrosis (CF) community have not been well studied.

中文翻译：